BioCentury
ARTICLE | Company News

4D Molecular Therapeutics, Pfizer deal

January 25, 2016 8:00 AM UTC

4D partnered with Pfizer to discover, develop and commercialize next-generation adeno-associated viral (AAV) vectors for cardiac indications using 4D’s Therapeutic Vector Evolution platform. 4D will r...